UPDATE: Glaxo "particularly pleased" with daprodustat Phase 3 results
UPDATE: Glaxo "particularly pleased" with daprodustat Phase 3 results
Read moreUPDATE: Glaxo "particularly pleased" with daprodustat Phase 3 results
Read moreIN BRIEF: ImmuPharma appoints COO Tim Franklin to board of directors
Read more(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* UK's coronavirus crisis could return -chief medical adviser* Burberry drops even after robust sales* GSK gains on successful late-stage tr...
Read moreTOP NEWS: Glaxo eyes developer to turn UK asset into life sciences hub
Read moreMILAN, July 13 (Reuters) - Italy approved the temporary distribution of a coronavirus antibody treatment by Britain's GlaxoSmithKline and U.S. company Vir Biotechnology , the health ministry said in a statement on Tuesday.The therapy, named Sotrov...
Read more* Vectura withdraws support for Carlyle deal* UK firm recommends Philip Morris offer* Deal is second by Philip Morris in a week* Shares jump 14% (Adds industry context, analyst comments, updates shares)By Yadarisa Shabong and Siddharth CavaleJuly 9 ...
Read more(Sharecast News) - WM Morrison: Berenberg downgrades to hold with a target price of 254p.
Read moreBROKER RATINGS: Berenberg says buy Shaftesbury, Capital & Counties
Read moreBy Stephen NellisJuly 7 (Reuters) - Nvidia Corp on Wednesday said it opened what it claims is the fastest UK supercomputer to outside researchers that include both academic scientists and commercial firms such as AstraZeneca PLC and GlaxoSmithKlin...
Read moreBROKER RATINGS: Jefferies cuts British Land and Landsec to Hold
Read moreMoody's raises GSK outlook to stable as tips debt cut amid spin-off
Read moreUPDATE: Glaxo joins Alector on brain treatment trials; backs leader
Read moreLONDON MARKET MIDDAY: Stocks edge higher ahead of US jobs report
Read moreTOP NEWS: GSK backs Walmsley to lead pharma after Elliott criticism
Read more* GSK backs CEO Walmsley to lead it after split* Says governance strengthened with scientific appointments* Says separation structure after feedback from many shareholders (Adds Elliott, analyst comment, updates share price)By Pushkala Aripaka and ...
Read more